Faeth Therapeutics (FTH) Common Equity (2020 - 2026)
Faeth Therapeutics (FTH) posted Common Equity of $172.96 million for Q2 2026, up 533.2% from $27.31 million a year earlier.
Powered by 
Analysis
Faeth Therapeutics (FTH) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Faeth Therapeutics' Common Equity came in at $18.59 million, down 51.6% from FY2024.
- Annual Common Equity has declined for four consecutive years.
- In prior years, Faeth Therapeutics' Common Equity was $38.39 million in FY2024 (-40.8%), $64.9 million in FY2023 (-37.2%), $103.41 million in FY2022 (-29.4%) and $146.51 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q1 2020.
- On a year-over-year basis, Common Equity increased in 1 of the last seven quarters, with growth averaging 37.5%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 533.2%; the weakest was Q4 2025, with a decline of 51.6%.
- According to Business Quant data, Common Equity for the three prior quarters was -$137.29 million (Q1 2026), $18.59 million (Q4 2025) and $23.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Faeth Therapeutics | 115.80 Mn | -319.66 Mn | - | 172.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172.96 Mn |
| Mar 31, 2026 | -137.29 Mn |
| Dec 31, 2025 | 18.59 Mn |
| Sep 30, 2025 | 23.01 Mn |
| Jun 30, 2025 | 27.31 Mn |
| Mar 31, 2025 | 31.99 Mn |
| Dec 31, 2024 | 38.39 Mn |
| Sep 30, 2024 | 45.78 Mn |
| Jun 30, 2024 | 52.19 Mn |
| Mar 31, 2024 | 58.47 Mn |
| Dec 31, 2023 | 64.90 Mn |
| Sep 30, 2023 | 71.00 Mn |
| Jun 30, 2023 | 79.20 Mn |
| Mar 31, 2023 | 94.85 Mn |
| Dec 31, 2022 | 103.41 Mn |
| Sep 30, 2022 | 113.99 Mn |
| Jun 30, 2022 | 125.92 Mn |
| Mar 31, 2022 | 135.31 Mn |
| Dec 31, 2021 | 146.51 Mn |
| Sep 30, 2021 | 155.21 Mn |
API Access
Faeth Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=FTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "FTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=FTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();